This company has been marked as potentially delisted and may not be actively trading. IVERIC bio (ISEE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Opna Bio Doses First Patient in Phase 1 Study in Multiple Myeloma with OPN-6602, an EP300/CBP Bromodomain InhibitorAugust 26, 2024 | venturebeat.comAstellas Pharma Inc (ALPMY)March 10, 2024 | investing.comApellis falls on potential EU snub for eye therapy (update)December 15, 2023 | msn.comAkoya Biosciences: 2024 Could Be The Year To Own Their StockDecember 7, 2023 | seekingalpha.comApellis adds safety warning to eye therapyDecember 1, 2023 | msn.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Consensus Rating of "Hold" by AnalystsShares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Free Report) have been given an average rating of "Hold" by the ten analysts that are currently covering the company, MarketBeat.com reports. Ten equities research analysts have rated the stock with a hold recommendation. The average 12-month target prAugust 14, 2023 | marketbeat.comAmalgamated Bank Reduces Stock Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)Amalgamated Bank cut its position in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) by 14.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,205 shares of the company's stock after sAugust 7, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Consensus Rating of "Hold" by BrokeragesIVERIC bio, Inc. (NASDAQ:ISEE - Get Free Report) has received an average recommendation of "Hold" from the ten research firms that are currently covering the company, MarketBeat reports. Ten investment analysts have rated the stock with a hold rating. The average 1-year target price among analystsJuly 20, 2023 | marketbeat.comState of New Jersey Common Pension Fund D Boosts Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)State of New Jersey Common Pension Fund D raised its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) by 12.4% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 120,410 shares of the company's sJuly 17, 2023 | marketbeat.comAstellas Completes Acquisition of Iveric BioJuly 11, 2023 | finance.yahoo.comTrading was temporarily halted for "ISEE" at 07:07 PM with a stated reason of "News pending."July 11, 2023 | marketbeat.comDnB Asset Management AS Takes $335,000 Position in IVERIC bio, Inc. (NASDAQ:ISEE)DnB Asset Management AS bought a new position in IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 13,770 shares of the company's stock, valued at approximately $July 9, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Acquired by Hennion & Walsh Asset Management Inc.Hennion & Walsh Asset Management Inc. boosted its position in IVERIC bio, Inc. (NASDAQ:ISEE - Free Report) by 4.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 78,946 shares of the company's stock aftJuly 5, 2023 | marketbeat.comB.Riley Financial Sticks to Its Hold Rating for IVERIC bio (ISEE)June 30, 2023 | markets.businessinsider.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Acquired by Chartwell Investment Partners LLCChartwell Investment Partners LLC increased its position in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 39.1% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 53,720 shares of the company's stock after purchasing an additional 15,095 sJune 27, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Receives Average Rating of "Hold" from AnalystsIVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) has been assigned an average recommendation of "Hold" from the ten analysts that are currently covering the stock, Marketbeat.com reports. Ten investment analysts have rated the stock with a hold recommendation. The average 12-month target price among anJune 25, 2023 | marketbeat.comVoya Investment Management LLC Purchases 171,434 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)Voya Investment Management LLC lifted its position in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 84.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 373,531 shares of the company's stock after acquiring an additional 171,434 shares dJune 24, 2023 | marketbeat.comIVERIC bio (NASDAQ:ISEE) Now Covered by Analysts at StockNews.comStockNews.com initiated coverage on shares of IVERIC bio in a research note on Tuesday. They issued a "sell" rating for the company.June 20, 2023 | marketbeat.comNeo Ivy Capital Management Purchases Shares of 17,910 IVERIC bio, Inc. (NASDAQ:ISEE)Neo Ivy Capital Management purchased a new stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 17,910 shares of the company's stock, valued at approximJune 16, 2023 | marketbeat.comEversept Partners LP Purchases New Shares in IVERIC bio, Inc. (NASDAQ:ISEE)Eversept Partners LP purchased a new stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 350,747 shares of the company's stock, valued at approJune 14, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by GSA Capital Partners LLPGSA Capital Partners LLP decreased its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 78.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 17,363 shares of the company's stock after selling 64,985 shaJune 9, 2023 | marketbeat.comAmerican International Group Inc. Buys 7,390 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)American International Group Inc. increased its position in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 13.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 63,652 shares of the compaJune 8, 2023 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)Principal Financial Group Inc. grew its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 10.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,705 shares of the company's stock after buyiJune 5, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by Moore Capital Management LPMoore Capital Management LP lowered its holdings in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 12.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 210,000 shares of the company's stock after sellJune 2, 2023 | marketbeat.comIVERIC bio, Inc. (NASDAQ:ISEE) Given Average Rating of "Hold" by BrokeragesIVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) has earned an average recommendation of "Hold" from the twelve analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating toMay 31, 2023 | marketbeat.comIveric bio, Still A 5+% OpportunityMay 30, 2023 | seekingalpha.comAnnexon (ANNX) Stock Down More Than 50% Last Week: Here's WhyMay 30, 2023 | finance.yahoo.comIVERIC bio, Inc. (NASDAQ:ISEE) Shares Sold by Artal Group S.A.Artal Group S.A. cut its holdings in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 20.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,000,000 shares of the company's stoMay 29, 2023 | marketbeat.comBayer, Amgen looked at Iveric before agreeing to Astellas sale - reportMay 23, 2023 | seekingalpha.comCitigroup Inc. Reduces Holdings in IVERIC bio, Inc. (NASDAQ:ISEE)Citigroup Inc. trimmed its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 64.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 179,348 shares of the company's stockMay 22, 2023 | marketbeat.comTimesSquare Capital Management LLC Makes New Investment in IVERIC bio, Inc. (NASDAQ:ISEE)TimesSquare Capital Management LLC bought a new position in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 1,011,640 shares of the company's stock, vMay 18, 2023 | marketbeat.comUnusual Call Option Trade in IVERIC bio (ISEE) Worth $1,780.50KMay 17, 2023 | msn.comArizona State Retirement System Boosts Stock Position in IVERIC bio, Inc. (NASDAQ:ISEE)Arizona State Retirement System boosted its holdings in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 45.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 32,123 shares of the company's stock aftMay 17, 2023 | marketbeat.comQ2 2023 EPS Estimates for IVERIC bio, Inc. Reduced by Analyst (NASDAQ:ISEE)IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) - Investment analysts at Wedbush lowered their Q2 2023 earnings estimates for shares of IVERIC bio in a research report issued on Wednesday, May 10th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings per share of ($0.5May 15, 2023 | marketbeat.comIVERIC Bio (NASDAQ: ISEE)May 11, 2023 | fool.comTD Cowen Downgrades IVERIC bio (ISEE)May 9, 2023 | msn.comSkandinaviska Enskilda Banken AB publ Reduces Stock Position in IVERIC bio, Inc. (NASDAQ:ISEE)Skandinaviska Enskilda Banken AB publ lessened its holdings in IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 0.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 790,802 shares of the company's stock afteMay 8, 2023 | marketbeat.comSHAREHOLDER ALERT: Weiss Law Investigates IVERIC bio, Inc.May 2, 2023 | marketwatch.comMoore Kuehn Encourages ISEE, MDWT, CBOF, and SGEN Investors to Contact Law FirmMay 2, 2023 | benzinga.comSwiss National Bank Buys 82,000 Shares of IVERIC bio, Inc. (NASDAQ:ISEE)Swiss National Bank lifted its stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE - Get Rating) by 42.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 275,200 shares of the company's stock after buying an additional 82,000 shares during the quaMay 2, 2023 | marketbeat.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IVERIC bio, Inc. BuyoutMay 1, 2023 | benzinga.comCheck Out What Whales Are Doing With ISEEMay 1, 2023 | benzinga.comAstellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'May 1, 2023 | finance.yahoo.comBiotech Buying Bonanza: Iveric Bio Snags $5.9 Billion Deal From Astellas PharmaMay 1, 2023 | finance.yahoo.comThese Stocks Are Moving the Most Today: First Republic, JPMorgan, Iveric Bio, SoFi, ON Semi, and MoreMay 1, 2023 | finance.yahoo.comFirst Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top StoriesMay 1, 2023 | finance.yahoo.comShareholder Alert: Ademi LLP investigates whether IVERIC bio, Inc. has obtained a Fair Price in its transaction with AstellasMay 1, 2023 | benzinga.comISEE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Iveric bio, Inc. Is Fair to ShareholdersMay 1, 2023 | technews.tmcnet.comIveric Bio Shares Rise Premarket on Takeover by Astellas >ISEEMay 1, 2023 | marketwatch.comIveric Bio Stock Surges. It's Being Bought by Astellas for $5.9 Billion.May 1, 2023 | msn.com Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter. Email Address ISEE Media Mentions By Week ISEE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ISEE News Sentiment▼0.450.85▲Average Medical News Sentiment ISEE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ISEE Articles This Week▼00▲ISEE Articles Average Week Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zenas Biopharma News Today PHAXIAM Therapeutics News Today Alpha Tau Medical News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Lexaria Bioscience News Today Nutriband News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ISEE) was last updated on 4/28/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IVERIC bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IVERIC bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ISEE Stock Free ISEE Stock Alerts